Tagger A, Ribero M L, Grossi A, Chiaramonte S, Bortolotti F, Tremolada F
Institute of Virology, University of Milan, Italy.
Nephron. 1992;61(3):258-9. doi: 10.1159/000186897.
Patients with post-transfusion, community-acquired or hemodialysis-acquired non-A, non-B hepatitis (NANBH) were tested for antibody to hepatitis C virus (HCV) during acute-phase and resolving or chronicized illness. HCV appears to be involved in most cases of post-transfusion and hemodialysis-acquired NANBH, but only in 40% of community-acquired NANBH. Second generation HCV antibody assays are more specific and sensitive, favoring early detection of HCV seroconversion and identification of HCV-antibody-positive individuals years after exposure to the virus.
对输血后、社区获得性或血液透析获得性非甲非乙型肝炎（NANBH）患者在急性期以及病情缓解期或慢性期进行丙型肝炎病毒（HCV）抗体检测。HCV似乎与大多数输血后和血液透析获得性NANBH病例有关，但仅与40%的社区获得性NANBH病例有关。第二代HCV抗体检测更具特异性和敏感性，有利于早期检测HCV血清转化以及识别接触病毒数年之后的HCV抗体阳性个体。
